Endocrinology, Vol 137, 1019-1024, Copyright © 1996 by Endocrine Society

ARTICLES

Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin- like growth factor-1 (IGF- I) receptor: comparative study using the yeast two-hybrid system

S Tartare-Deckert, J Murdaca, D Sawka-Verhelle, KH Holt, JE Pessin and E Van Obberghen
INSERM, Nice Cedex 2, France.

Activation of the phosphatidyl inositol 3-kinase (PI 3-kinase) is one of the immediate events in signaling by the insulin receptor (IR) and the insulin-like growth factor-1 receptor (IGF-IR). The IR and IGF-IR are two closely related tyrosine kinases, which are activated on binding of their respective ligands. Previous studies have proposed that the two receptors interact directly with the SH2 domains of the Mr 85K regulatory subunit (p85) of PI 3- kinase via phosphorylated Y1322THM and Y1316AHM sequences located in the carboxyl-terminal domain of the IR and the IGF-IR, respectively. We In this study we have used the yeast two-hybrid system to compare the interaction of the cytoplasmic domains of the IR and the IGF-IR with p85. We found that the IR is more efficient in interacting with the p85 than is the IGF- IR. For both receptors, deletion of the region containing the Y1322THM sequence in the IR and the Y1316AHM-similar sequence in the IGF-IR decreases their ability to interact with p85. However, these mutated receptors still interacted with the full-length p85, suggesting that other regions in the receptors might be involved in the interaction. Furthermore, mutations of the three major autophosphorylation sites indicate that interactions with p85 are dependent on the receptor tyrosine kinase activity. Finally, we asked whether the two SH2 domains of p85 (n-SH2 and c-SH2) are involved in the same fashion in their association with the two receptors. Interestingly, we observed that the carboxyl- terminal domain of the IGF-IR associates only with the p85 c- SH2 domain, whereas the corresponding domain of the IR interacts with both the n-SH2 and the c-SH2 domains. In combination, both SH2 domains (n/c-SH2) contribute to the maximal interaction observed with the full- length p85. Although the precise impact on signaling resulting from these differences in the interaction of p85 with the IR vs. the IGF-IR remains to be determined, it is tempting to propose that they contribute, at least in part, to the specificity of the biological responses induced by insulin vs. IGF-1.

This article has been cited by other articles:

				C. Osipo, K. Meeke, H. Liu, D. Cheng, S. Lim, A. Weichel, and V. C. Jordan Trastuzumab Therapy for Tamoxifen-Stimulated Endometrial Cancer Cancer Res., September 15, 2005; 65(18): 8504 - 8513. [Abstract] [Full Text] [PDF]

				K. D. Moon, C. B. Post, D. L. Durden, Q. Zhou, P. De, M. L. Harrison, and R. L. Geahlen Molecular Basis for a Direct Interaction between the Syk Protein-tyrosine Kinase and Phosphoinositide 3-Kinase J. Biol. Chem., January 14, 2005; 280(2): 1543 - 1551. [Abstract] [Full Text] [PDF]

				C. C. King and A. C. Newton The Adaptor Protein Grb14 Regulates the Localization of 3-Phosphoinositide-dependent Kinase-1 J. Biol. Chem., September 3, 2004; 279(36): 37518 - 37527. [Abstract] [Full Text] [PDF]

				U. Hermanto, C. S. Zong, W. Li, and L.-H. Wang RACK1, an Insulin-Like Growth Factor I (IGF-I) Receptor-Interacting Protein, Modulates IGF-I-Dependent Integrin Signaling and Promotes Cell Spreading and Contact with Extracellular Matrix Mol. Cell. Biol., April 1, 2002; 22(7): 2345 - 2365. [Abstract] [Full Text] [PDF]

				J. J. Kim, B.-C. Park, Y. Kido, and D. Accili Mitogenic and Metabolic Effects of Type I IGF Receptor Overexpression in Insulin Receptor-Deficient Hepatocytes Endocrinology, August 1, 2001; 142(8): 3354 - 3360. [Abstract] [Full Text] [PDF]

				B. Emanuelli, P. Peraldi, C. Filloux, D. Sawka-Verhelle, D. Hilton, and E. Van Obberghen SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling J. Biol. Chem., May 19, 2000; 275(21): 15985 - 15991. [Abstract] [Full Text] [PDF]

				A. V. Lee, J. L. Gooch, S. Oesterreich, R. L. Guler, and D. Yee Insulin-Like Growth Factor I-Induced Degradation of Insulin Receptor Substrate 1 Is Mediated by the 26S Proteasome and Blocked by Phosphatidylinositol 3'-Kinase Inhibition Mol. Cell. Biol., March 1, 2000; 20(5): 1489 - 1496. [Abstract] [Full Text]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				C. Arbet-Engels, S. Tartare-Deckert, and W. Eckhart C-terminal Src Kinase Associates with Ligand-stimulated Insulin-like Growth Factor-I Receptor J. Biol. Chem., February 26, 1999; 274(9): 5422 - 5428. [Abstract] [Full Text] [PDF]

				A Bavelloni, S Santi, A Sirri, M Riccio, I Faenza, N Zini, S Cecchi, A Ferri, P Auron, N. Maraldi, et al. Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells J. Cell Sci., January 3, 1999; 112(5): 631 - 640. [Abstract] [PDF]

				A. Kasus-Jacobi, D. Perdereau, C. Auzan, E. Clauser, E. Van Obberghen, F. Mauvais-Jarvis, J. Girard, and A.-F. Burnol Identification of the Rat Adapter Grb14 as an Inhibitor of Insulin Actions J. Biol. Chem., October 2, 1998; 273(40): 26026 - 26035. [Abstract] [Full Text] [PDF]

				V. A. Blakesley, A. P. Koval, B. S. Stannard, A. Scrimgeour, and D. LeRoith Replacement of Tyrosine 1251 in the Carboxyl Terminus of the Insulin-like Growth Factor-I Receptor Disrupts the Actin Cytoskeleton and Inhibits Proliferation and Anchorage-independent Growth J. Biol. Chem., July 17, 1998; 273(29): 18411 - 18422. [Abstract] [Full Text] [PDF]

				J. F. Kuemmerle and T. L. Bushman IGF-I stimulates intestinal muscle cell growth by activating distinct PI 3-kinase and MAP kinase pathways Am J Physiol Gastrointest Liver Physiol, July 1, 1998; 275(1): G151 - G158. [Abstract] [Full Text] [PDF]

				R. G. Richards, M. P. Walker, J. Sebastian, and R. P. DiAugustine Insulin-like Growth Factor-1 (IGF-1) Receptor-Insulin Receptor Substrate Complexes in the Uterus. ALTERED SIGNALING RESPONSE TO ESTRADIOL IN THE IGF-1m/m MOUSE J. Biol. Chem., May 8, 1998; 273(19): 11962 - 11969. [Abstract] [Full Text] [PDF]

				C. M. Boney, R. M. Smith, and P. A. Gruppuso Modulation of Insulin-Like Growth Factor I Mitogenic Signaling in 3T3-L1 Preadipocyte Differentiation Endocrinology, April 1, 1998; 139(4): 1638 - 1644. [Abstract] [Full Text] [PDF]

				I. Mothe, L. Delahaye, C. Filloux, S. Pons, M. F. White, and E. Van Obberghen Interaction of Wild Type and Dominant-Negative p55PIK Regulatory Subunit of Phosphatidylinositol 3-Kinase with Insulin-Like Growth Factor-1 Signaling Proteins Mol. Endocrinol., December 1, 1997; 11(13): 1911 - 1923. [Abstract] [Full Text] [PDF]

				S. Manes, E. Mira, M. d. M. Barbacid, A. Cipres, P. Fernandez-Resa, J. M. Buesa, I. Merida, M. Aracil, G. Marquez, and C. Martinez-A Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3 J. Biol. Chem., October 10, 1997; 272(41): 25706 - 25712. [Abstract] [Full Text] [PDF]

				P. Sachdev, Y.-X. Jiang, W. Li, T. Miki, H. Maruta, M. S. A. Nur-e-Kamal, and L.-H. Wang Differential Requirement for Rho Family GTPases in an Oncogenic Insulin-like Growth Factor-I Receptor-induced Cell Transformation J. Biol. Chem., July 6, 2001; 276(28): 26461 - 26471. [Abstract] [Full Text] [PDF]

				T. Ligensa, S. Krauss, D. Demuth, R. Schumacher, J. Camonis, G. Jaques, and K. M. Weidner A PDZ Domain Protein Interacts with the C-terminal Tail of the Insulin-like Growth Factor-1 Receptor but Not with the Insulin Receptor J. Biol. Chem., August 31, 2001; 276(36): 33419 - 33427. [Abstract] [Full Text] [PDF]